SpectrumX Confirms Scientific Advice Meeting With MHRA, Proposed Timeline for Human Clinical Trials for Ground-Breaking Medicine SPX-001
The Company identifies critical milestones required to commence clinical trial programme LONDON–(BUSINESS WIRE)–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce that is has a date for a scientific advice meeting with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to discuss its human clinical trial programme. SpectrumX has confirmed the scientific … [Read more…]
